2002-es idegen nyelvű publikációk

  • Ajzner, É., Balogh, I., Szabó, T., Marosi, A., Haramura, G., Muszbek, L.: Severe coagulation factor V deficiency caused by two novel frameshift mutations: 2952delT in exon 13 and 5493insG in exon 16 of factor 5 gene Blood 99: 702-5 (2002)
  • Sarvari, M., Kárpáti, L., Fésüs, L., Deli, L, Muszbek, L., Nemes, Z.: Competitive enzyme-linked immonosorbent assay for N( varepsilon )(gamma-glutamyl)lysine. Anal Biochem. 311(2): 187-90 (2002)
  • Soltész P, Aleksza M, Antal-Szalmás P , Lakos G, Szegedi Gy, Kiss E: Plasmapheresis modulates Th1/Th2 imbalance in patients with systemis lupus erythematosous according to measurement of intracytoplasmic cytokines. Autoimmunity. 35: 51-6 (2002)
  • Irinyi B, Aleksza M, Antal-Szalmás P , Sipka S, Hunyadi J, Szegedi A: Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria. Acta Dermatol Venereol. 82: 249-53 (2002)
  • Aleksza M, Lukacs A, Antal-Szalmas P , Hunyadi J, Szegedi A. Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis. Brit J Dermatol. 147: 1135-41 (2002)
  • Bodolay E, Aleksza M, Antal-Szalmas P , Vegh J, Szodoray P, Soltesz P, Szegedi A, Szekanecz Z. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. J Rheumatol. 29: 2136-42 (2002)
  • Meiring MS, Litthauer D, Harsfalvi J , van Wyk V, Badenhorst PN, Kotze HF. In vitro effect of a thrombin inhibition peptide selected by phage display technology. Thromb Res. 107(6):365-71 (2002)
  • Dardik R, Shenkman B, Tamarin I, Eskaraev R, Harsfalvi J, Varon D, Inbal A: Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins Thromb Res. 105(4):317-23 (2002)
  • Novak L, Deckmyn H, Damjanovich S, Harsfalvi J: Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood. 99(6):2070-6 (2002)
  • Kappelmayer J, Karászi É , Telek B, Jakab K. “Pros and cons” on how to measure drug resistance in leukemias. Leuk Lymph 43: 711-717 (2002)
  • Jakab Z, Balogh E, Karászi E, Kappelmayer J , Kiss C, Olah E. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): Do outcomes differ from t (4, 11) Med Ped Oncol 39: 63-65 (2002)
  • K. Pető, A.V. Oláh , E. Bráth, I. Furka, I. Mikó: Relative antioxidant activity in relation with renal ischemia-reperfusion injury Eur. Surg. Res . 34 (suppl 1): 83 (2002)
  • Mikó I., Furka A., Ács G., Németh N., Sipka S., Oláh V.A ., Bráth E., Furka I.: Laboratory follow up of spleen autotransplants after experimantal spleen injuries. Eur. Surg. Res . (Suppl.) 189/34: 10-12 (2002)
  • Csáthy L., Oláh V.A ., Clemens B., György I. , Varga J.: Is there any tubular side effects of long-term antiepileptic treatment in children? J Salud (i) Ciencia (SIIC), (2002) (interneten elérhető)

Frissítés dátuma: 2019.06.27.